Special AT-rich sequence-binding protein 2 suppresses invadopodia formation in HCT116 cells via palladin inhibition

Experimental Cell Research

Volumn 332, Issue 1, 2015, Pages 78-88

  Mansour, Mohammed A ^a,b   Asano, Eri ^a   Hyodo, Toshinori ^a   Akter, K A ^a   Takahashi, Masahide ^a   Hamaguchi, Michinari ^a   Senga, Takeshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tanta University   (Egypt)

Author keywords

Colorectal cancer; Invadopodia; Palladin; SATB2

Indexed keywords

ACTIN; BINDING PROTEIN; CORTACTIN; F ACTIN; MOLECULAR SCAFFOLD; PALLADIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 2; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; MATRIX ATTACHMENT REGION BINDING PROTEIN; PALLADIN PROTEIN, HUMAN; PHOSPHOPROTEIN; SATB2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER CELL LINE; CYTOSKELETON; DOWN REGULATION; EXTRACELLULAR MATRIX; HCT116 CELL LINE; INVADOPODIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; CELL MOTION; CELL SURFACE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

CELL MOVEMENT; CELL SURFACE EXTENSIONS; CYTOSKELETAL PROTEINS; HCT116 CELLS; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; PHOSPHOPROTEINS; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS;

EID: 84924407101     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.12.003     Document Type: Article

References (27)

1. Weitz J., Koch M., Debus J., Höhler T., Galle P.R., Büchler M.W. Colorectal cancer. Lancet 2005, 365(9454):153-165.
2. Dobreva G., Dambacher J., Grosschedl R. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev. 2003, 17(24):3048-3061.
3. FitzPatrick D.R., Carr I.M., McLaren L., Leek J.P., Wightman P., Williamson K., et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum. Mol. Genet. 2003, 12(19):2491-2501.
4. Britanova O., Akopov S., Lukyanov S., Gruss P., Tarabykin V. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur. J. Neurosci. 2005, 21(3):658-668.
5. Dobreva G., Chahrour M., Dautzenberg M., et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 2006, 125(5):971-986.
6. Britanova O., Depew M.J., Schwark M., et al. Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. Am. J. Hum. Genet. 2006, 79(4):668-678.
7. Rosenfeld J.A., Ballif B.C., Lucas A., et al. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. PLoS One 2009, 4(8):e6568.
8. Liu T.R., Xu L.H., Yang A.K., Zhong Q., Song M., Li M.Z., et al. Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients. PloS One 2012, 7(7):e40704.
9. Wang S., Zhou J., Wang X.Y., Hao J.M., Chen J.Z., Zhang X.M., et al. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J. Pathol. 2009, 219(1):114-122.
10. Eberhard J., Gaber A., Wangefjord S., Nodin B., Uhlen M., Ericson Lindquist K., et al. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br. J. Cancer 2012, 106(5):931-938.
11. Rachlin A.S., Otey C.A. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin. J. Cell Sci. 2006, 119(Pt 6):995-1004.
12. Jin L. The actin associated protein palladin in smooth muscle and in the development of diseases of the cardiovasculature and in cancer. J. Muscle Res. Cell Motil. 2011, 32(1):7-17.
13. Parast M.M., Otey C.A. Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J. Cell Biol. 2000, 150(3):643-656.
14. Goicoechea S., Arneman D., Disanza A., Garcia-mata R., Scita G., Otey C.A. Palladin binds to Eps8 and enhances the formation of dorsal ruffles and podosomes in vascular smooth muscle cells. J. Cell Sci. 2006, 119(Pt 16):3316-3324.
15. Goicoechea S.M., Bednarski B., García-mata R., Prentice-dunn H., Kim H.J., Otey C.A. Palladin contributes to invasive motility in human breast cancer cells. Oncogene 2009, 28(4):587-598.
16. Goicoechea S.M., Bednarski B., Stack C., et al. Isoform-specific upregulation of palladin in human and murine pancreas tumors. PLoS One 2010, 5(4):e10347.
17. Goicoechea S.M., García-mata R., Staub J., et al. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Oncogene 2014, 33(10):1265-1273.
18. Von nandelstadh P., Gucciardo E., Lohi J., et al. Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton. Mol. Biol. Cell 2014, 25(17):2556-2570.
19. Asano E., Maeda M., Hasegawa H., et al. Role of palladin phosphorylation by extracellular signal-regulated kinase in cell migration. PLoS One 2011, 6(12):e29338.
20. Najm P., El-sibai M. Palladin regulation of the actin structures needed for cancer invasion. Cell Adhes. Migr. 2014, 8(1):29-35.
21. Leong H.S., Robertson A.E., Stoletov K., et al. Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep 2014, 8(5):1558-1570.
22. Shah N., Sukumar S. The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer. 2010, 10(5):361-371.
23. Gong Y., Xu F., Zhang L., et al. MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells. Mol. Cell Biochem. 2014, 387(1-2):227-239.
24. Maeda M., Asano E., Ito D., et al. Characterization of interaction between CLP36 and palladin. FEBS J. 2009, 276(10):2775-2785.
25. Tay P.N., Tan P., Lan Y., et al. Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells. Int. J. Oncol. 2010, 37(4):909-926.
26. Chin Y.R., Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol. Cell 2010, 38(3):333-344.
27. Chin Y.R., Toker A. Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin. Cell Adhes. Migr. 2011, 5(3):211-214.